科尔迪亚尔首次在人体上的临床试验的逻辑和设计:一种吸附剂辅助的连续流膜透析系统
Joost Christiaan de Vries1, Maaike K van Gelder1, Dian P Bolhuis1
1Department of Nephrology & Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
概括
吸附剂辅助腹膜透析 (SAPD) 是一种新的治疗方法,可以改善溶液清除并减少并发症. 这项首次在人身上进行的试验评估了其在稳定患者中的安全性和性能.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物医学工程 生物医学工程
- 医疗器械 医疗器械
背景情况:
- 腹腔透析 (PD) 面临着诸如低溶解物清除率和有限的技术存活率等挑战.
- 血液透析是一种替代方法,但有其自身的局限性.
- 一个新的吸附剂辅助腹透析 (SAPD) 系统提供了潜在的改善.
研究的目的:
- 评估SAPD的短期临床安全性和性能.
- 评估SAPD在增强血清理和超的疗效.
- 为了确定患者对SAPD治疗的耐受性.
主要方法:
- 这是一项首次在人身上进行的临床试验,涉及12名稳定的成人PD患者.
- 透析液通过单透管进行连续循环.
- 使用吸附剂再生耗尽的透析液.
主要成果:
- SAPD显示了提高尿液溶液的血清除的潜力.
- 治疗可以通过减少葡萄糖负载和导管操纵来保持腹膜完整性.
- 初步数据表明患者可以接受的耐受性.
结论:
- SAPD是腹膜透析的一个有前途的新方法.
- 需要进一步的研究来确认长期的疗效和安全性.
- SAPD可能提供一种改进的PD模式,降低腹膜炎的风险和更好的溶液清除.
相关概念视频
Peritoneal Dialysis I: Introduction and Procedure
2.4K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
2.4K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
549
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
549
Peritoneal Dialysis III: Nursing Management
665
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
665
Hemodialysis I: Introduction
1.4K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.4K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
176
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
176
Dialysis
1.6K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K


